Bornstein SR, de Zeeuw D, Heerspink HJL, Schulze F, et al. Aldosterone synthase inhibitor (BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double-blind, placebo-controlled, Phase I trial. Diabetes Obes Metab 2024 Mar 18. doi: 10.1111/dom.15518.
PMID: 38497241